X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs IPCA LABS - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH IPCA LABS STERLING BIOTECH/
IPCA LABS
 
P/E (TTM) x -1.6 45.1 - View Chart
P/BV x 0.1 3.5 1.8% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 STERLING BIOTECH   IPCA LABS
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
IPCA LABS
Mar-17
STERLING BIOTECH/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs11643 1.6%   
Low Rs3503 0.7%   
Sales per share (Unadj.) Rs26.8254.4 10.5%  
Earnings per share (Unadj.) Rs-15.016.1 -93.1%  
Cash flow per share (Unadj.) Rs-5.529.8 -18.3%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs54.9194.6 28.2%  
Shares outstanding (eoy) m267.87126.20 212.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.32.3 11.5%   
Avg P/E ratio x-0.535.7 -1.3%  
P/CF ratio (eoy) x-1.319.2 -6.6%  
Price / Book Value ratio x0.12.9 4.3%  
Dividend payout %06.2 0.0%   
Avg Mkt Cap Rs m1,86272,300 2.6%   
No. of employees `0001.413.3 10.2%   
Total wages/salary Rs m5476,960 7.9%   
Avg. sales/employee Rs Th5,303.32,413.5 219.7%   
Avg. wages/employee Rs Th403.8523.2 77.2%   
Avg. net profit/employee Rs Th-2,959.0152.4 -1,941.0%   
INCOME DATA
Net Sales Rs m7,18132,106 22.4%  
Other income Rs m43226 18.9%   
Total revenues Rs m7,22332,332 22.3%   
Gross profit Rs m9474,448 21.3%  
Depreciation Rs m2,5431,730 147.0%   
Interest Rs m4,377241 1,817.7%   
Profit before tax Rs m-5,9312,703 -219.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924675 -285.0%   
Profit after tax Rs m-4,0072,028 -197.6%  
Gross profit margin %13.213.9 95.2%  
Effective tax rate %32.425.0 129.9%   
Net profit margin %-55.86.3 -883.3%  
BALANCE SHEET DATA
Current assets Rs m14,33517,340 82.7%   
Current liabilities Rs m49,8099,559 521.1%   
Net working cap to sales %-494.024.2 -2,038.6%  
Current ratio x0.31.8 15.9%  
Inventory Days Days403100 402.2%  
Debtors Days Days17157 300.1%  
Net fixed assets Rs m55,43220,779 266.8%   
Share capital Rs m268252 106.1%   
"Free" reserves Rs m13,93524,499 56.9%   
Net worth Rs m14,70124,553 59.9%   
Long term debt Rs m9,4783,517 269.5%   
Total assets Rs m73,98839,595 186.9%  
Interest coverage x-0.412.2 -2.9%   
Debt to equity ratio x0.60.1 450.0%  
Sales to assets ratio x0.10.8 12.0%   
Return on assets %0.55.7 8.7%  
Return on equity %-27.38.3 -329.9%  
Return on capital %-6.410.5 -61.3%  
Exports to sales %25.948.6 53.2%   
Imports to sales %0.214.2 1.2%   
Exports (fob) Rs m1,86015,617 11.9%   
Imports (cif) Rs m124,571 0.3%   
Fx inflow Rs m1,86015,617 11.9%   
Fx outflow Rs m255,828 0.4%   
Net fx Rs m1,8359,790 18.7%   
CASH FLOW
From Operations Rs m1,7192,764 62.2%  
From Investments Rs m-3,148-1,432 219.9%  
From Financial Activity Rs m1,426-1,591 -89.6%  
Net Cashflow Rs m-3-259 1.3%  

Share Holding

Indian Promoters % 33.9 45.9 73.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.4 -  
FIIs % 9.9 25.3 39.1%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 17.4 225.9%  
Shareholders   21,482 36,892 58.2%  
Pledged promoter(s) holding % 55.9 2.1 2,614.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   SHASUN PHARMA  DR. REDDYS LAB  TORRENT PHARMA  UNICHEM LAB  MERCK LTD  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Strong; Metal, Pharma Stocks Lead Gains(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are presently trading above the dotted line.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Feb 23, 2018 02:09 PM

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS